Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.13 - $12.25 $24,949 - $97,644
-7,971 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$9.54 - $14.26 $18,936 - $28,306
-1,985 Reduced 19.94%
7,971 $90,000
Q3 2021

Nov 15, 2021

SELL
$8.05 - $13.29 $92,470 - $152,662
-11,487 Reduced 53.57%
9,956 $88,000
Q2 2021

Aug 16, 2021

BUY
$11.76 - $16.85 $153,079 - $219,336
13,017 Added 154.49%
21,443 $263,000
Q3 2020

Nov 17, 2020

BUY
$11.74 - $22.0 $38,072 - $71,346
3,243 Added 62.57%
8,426 $156,000
Q2 2020

Aug 17, 2020

BUY
$5.67 - $15.86 $29,387 - $82,202
5,183 New
5,183 $63,000

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $30.3M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.